Issue |
Title |
File |
Vol 11, No 1 (2025) |
Features of the course of osteoarthritis in patients with asymptomatic hyperuricemia |
|
Bashkinov R.A., Mazurov V.I., Gaydukova I.Z., Inamova O.V., Petrova M.S.
|
Vol 10, No 5 (2024) |
Febuxostat: efficacy and safety of the drug, prospects for application (literature review) |
|
Shchemeleva E.V., Skorodumova E.A.
|
Vol 9, No 6 (2023) |
Federal clinical recommendations for sarcoidosis diagnosis and treatment: accents and comments |
|
Vizel A.A., Avdeev S.N., Malyavin A.G., Shmelev E.I., Vizel I.Y.
|
Vol 9, No 8 (2023) |
Fixed combination of levocetirizine and montelukast in the treatment of allergic rhinitis |
|
Bolieva L.Z., Moulid A., Basieva A.T.
|
Vol 9, No 10 (2023) |
From empirical medicine – to analytical medicine |
|
Volkova N.I., Volkov A.V.
|
Vol 9, No 2 (2023) |
Gastrointestinal lesions in COVID-19 |
|
Belova G.V.
|
Vol 9, No 8 (2023) |
Gastropathy associated with antiplatelet and anticoagulant therapy: prevalence and risk factors |
|
Golendyaeva P.I., Livzan M.A., Gaus O.V., Korennova O.Y., Mozgovoy S.I.
|
Vol 10, No 1 (2024) |
Gender peculiarities of clinical manifestations in patients with arterial hypertension and chronic heart failure in combination with senile asthenia syndrome |
|
Safronenko V.A., Chesnikova A.I.
|
Vol 10, No 3 (2024) |
Gilbert’s syndrome concerning a new look at the effects of hyperbilirubinemia |
|
Gerasimenko I.V., Morozov N.T., Gerasimenko A.A.
|
Vol 10, No 4 (2024) |
Gliflozins as remedies for correction of neurological complications of non-alcoholic fatty liver disease. Part 1 |
|
Prikhodko V.A., Okovityi S.V.
|
Vol 10, No 5 (2024) |
Gliflozins as remedies for correction of non-alcoholic fatty liver disease neurological complications. Part 2 |
|
Prikhodko V.A., Okovityi S.V.
|
Vol 9, No 7 (2023) |
Grishmanovskaya O.N. Possibilities for diagnostics of non-alcoholic fatty liver disease in patients with metabolically associated comorbid pathology |
|
Aryamkina O.L., Dobrynina I.Y., Biek A.Y., Saitov A.R., Tarasova L.V., Zapevalov A.V., Grishmanovsky P.V., Grishmanovskaya O.N.
|
Vol 9, No 8 (2023) |
Gut microbiome modulation and cardiovascular risks: mechanisms of formation and correction |
|
Livzan M.A., Bikbavova G.R., Safiulina T.A., Loginova E.N.
|
Vol 9, No 9 (2023) |
Healthy lifestyle devotion index as a possible indicator of more severe course of novel coronavirus infection and long-term recovery |
|
Larina V.N., Ryzhikh A.A.
|
Vol 11, No 2 (2025) |
Heart failure in Krasnodar territory: Analysis of the current situation and ways of its improvement |
|
Karibova M.V., Kruchinova S.V., Gendugova M.N., Kosmacheva E.D.
|
Vol 9, No 6 (2023) |
Hereditary gout in a young woman with allopurinol intolerance |
|
Garanin A.A., Lebedev P.A., Paranina E.V.
|
Vol 9, No 8 (2023) |
Historical aspects of the protest anti-vaccination movement and possible ways to overcome it |
|
Osadchuk A.M., Loranskaya I.D., Osadchuk M.A.
|
Vol 10, No 5 (2024) |
Hormonal testosterone replacement therapy in young male patients with hypogonadism and erectile dysfunction after the past COVID-19 |
|
Beroeva M.R., Mkrtumyan A.M.
|
Vol 11, No 1 (2025) |
How to avoid missing a systemic sclerosis sine scleroderma in a patient with pulmonary arterial hypertension |
|
Yudkina N.N., Volkov A.V.
|
Vol 10, No 2 (2024) |
How to increase the safety of antithrombotic therapy in cardiology patients |
|
Vorobyeva N.M., Malaya I.P., Zakiev V.D., Tkacheva O.N.
|
Vol 9, No 8 (2023) |
Hyperammoniemia: new aspects of etiopathogenesis |
|
Pan A.A., Zaykova-Khelimskaya I.V., Alexeenko S.A.
|
Vol 9, No 3 (2023) |
Hyperuricemia and reduced glomerular filtration rate in the population among Nizhny Novgorod region inhabitants |
|
Borovkova N.Y., Kurashin V.K., Tokareva A.S., Makarova E.V., Nekrasov A.A., Savitskaya N.N., Mironov M.A.
|
Vol 10, No 6 (2024) |
Hypokalemia in a patient with heart failure and atrial fibrillation as a predictor of life-threatening arrhythmia |
|
Tatarintseva Z.G., Katushkina Y.A., Kosmacheva E.D., Babicheva O.V.
|
Vol 9, No 8 (2023) |
Hyposphagma as a manifestation of nutritional severe vitamin B12 deficiency anemia |
|
Chulkov V.S., Okonenko T.I., Rumyantsev E.E., Zhmaylova S.V.
|
Vol 9, No 6 (2023) |
Idiopathic pulmonary hypertension (autopsy observation) |
|
Vasyukova O.A., Tsareva N.A., Chernyaev A.L., Mikhaleva L.M., Samsonova M.V.
|
Vol 9, No 2 (2023) |
III All-Russian meeting of student scientific circles of medical universities "the use of genetically engineered biological drugs in the treatment of internal diseases" |
|
Board E.
|
Vol 10, No 2 (2024) |
Immunological aspects of acute kidney injury in patients with liver cirrhosis |
|
Karzakova L.M., Ivanova A.L., Abyzov I.N., Sidorov I.A., Tarasova L.V., Odintsova A.V.
|
Vol 11, No 1 (2025) |
Impact of hyperuricemia at the clinical course of systemic lupus erythematosus and comorbid conditions in young and middle-aged female patients |
|
Musiychuk M.M., Gaydukova I.Z., Mazurov V.I., Inamova O.V., Aliev D.B., Lapin S.V.
|
Vol 9, No 7 (2023) |
Impact of long-term antiarrhythmic therapy on the progression of atrial fibrillation from paroxysmal to permanent form |
|
Tarzimanova A.I.
|
Vol 9, No 3 (2023) |
Impact of novel coronavirus infection COVID-19 on the development of acute kidney injury and peculiarities of chronic kidney disease clinical course: Literature review |
|
Bochkareva V.O., Demko I.V., Petrova M.M., Obukhova I.A., Kozlov E.V.
|
Vol 10, No 2 (2024) |
Impact of osteoarthritis on the asthma clinical course: focus on physical activity and quality of life |
|
Budnevsky A.V., Tribuntseva L.V., Chernik T.A., Ivanchuk Y.S., Kravchenko A.Y.
|
Vol 10, No 8 (2024) |
Importance and efficacy of immunoprophylaxis of pneumococcal infection in adult population |
|
Nikolaeva S.V., Pogorelova O.O., Sharavina Y.A., Kokoev V.V.
|
Vol 9, No 7 (2023) |
Improving the effectiveness of rehabilitation treatment of a patient who has suffered an ischemic stroke |
|
Kamchatnov P.R., Prikazchikov S.V., Osmaeva Z.K., Chugunov A.V.
|
Vol 10, No 3 (2024) |
In memory of Galina Nikolaevna Gorokhovskaya (1935–2024) |
|
Editorial B.
|
Vol 10, No 4 (2024) |
Incidence degree and clinical significance of first detected hypothyroidia in patients with ST-segment elevation myocardial infarction |
|
Gridneva Y.Y., Chesnikova A.I., Safronenko V.A., Edlenko E.V., Zatloukal M.Y.
|
Vol 9, No 3 (2023) |
Increasing of glomeral filtration rate in the setting of serum uric acid normalization in high cardiovascular risk patients – clinical observations |
|
Gaydukova I.Z., Mazurov V.I., Inamova O.V., Tsinzerling A.Y., Bashkinov R.A.
|
Vol 9, No 4 (2023) |
Indapamide in the treatment of arterial hypertension |
|
Syrov A.V.
|
Vol 9, No 8 (2023) |
Indexes of left ventricle contractive function in persons after acute coronary event, depending on the presence of diabetes mellitus and sodium-glucose transporter inhibitors type 2 use |
|
Nevzorova V.A., Semenova P.A., Zakharchuk N.V., Ivina A.V.
|
Vol 9, No 3 (2023) |
Indicators of systemic inflammation and state of the cardiovascular system in patients with chronic kidney disease |
|
Zhmurov D.V., Zhmurov V.A., Petrov I.M., Petelina T.I., Gapon L.I., Yaroslavskaya E.I., Petrova Y.A., Oskolkov S.A., Zhmurova E.A., Vanuito E.Y., Ermakova A.A., Ermakova P.A.
|
Vol 9, No 9 (2023) |
Infectious endocarditis in a patient with a transplanted kidney on a conventional hemodialysis |
|
Kozlova A.A., Agafonova Y.S., Timofeev R.G., Mayorov V.V., Merkusheva E.P., Kokorin V.A.
|
Vol 9, No 1 (2023) |
Influence of comorbid pathology at the course of spondyloarthritis in patients receiving genetically engineered biological therapy |
|
Samigullina R.R., Vasilenko E.A., Mazurov V.I.
|
Vol 10, No 9 (2024) |
Influence of fixed combination of perindopril and amlodipine at cardiovascular remodeling in patients with stable ischemic heart disease after percutaneous coronary intervention |
|
Iskenderov B.G., Lokhina T.V., Denisova A.G., Berenshtein N.V., Molokova E.A.
|
Vol 10, No 6 (2024) |
Influence of hyperuricemia at the efficacy of hypolypidemic therapy in patients with chronic forms of ischemic heart disease |
|
Sergeeva O.S., Salamatova V.N., Kotova Y.A., Shevtsov A.N., Shevtsova V.I.
|
Vol 9, No 9 (2023) |
Influence of obesity at frailty syndrome manifestations in persons over 75 years old |
|
Evgenieva A.V., Noskov S.M., Zhomova M.V., Lavrukhina A.A.
|
Vol 9, No 8 (2023) |
Influence of vascular remodelling and reduced heart rate variability at indapamide efficacy in patients with arterial hypertension |
|
Iskenderov B.G., Lokhina T.V., Mozhzhukhina I.N., Berenshtein N.V., Zaitseva A.V.
|
Vol 11, No 1 (2025) |
Influence of vibro-hazardous production at the clinical course of diabetes mellitus type 2 |
|
Oleinik V.S., Davydova E.V.
|
Vol 9, No 5 (2023) |
Infraptellar nerve neuropathy as a cause of chronic pain in knee joint area |
|
Lyalina V.V., Skripnichenko E.A., Borisovskaya S.V., Oknin V.Y., Migachev S.L., Plieva Z.K., Lazko F.L., Baskov A.V., Belykh Y.A., Nikitin I.G.
|
Vol 9, No 6 (2023) |
Injuries of thoracic cage |
|
Zaitsev A.A., Davydov D.V., Chuprina A.P., Sergoventsev A.A., Malyavin A.G.
|
Vol 9, No 2 (2023) |
Insomnia as a comorbid disorder |
|
Golovatyuk A.O., Kochetkov A.I., Остроумова T.M., Ostroumova O.D., Poluektov M.G.
|
Vol 9, No 1 (2023) |
International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol® and Mexidol® FORTE 250 in patients with chronic brain ischemia (memo): subanalysis in patients with arterial hypertension |
|
Zakharov V.V., Ostroumova O.D., Kochetkov A.I., Klepikova M.V., Fedin A.I.
|
Vol 11, No 1 (2025) |
Intra-articular introduction of hyaluronic acid in patients with early osteoarthritis |
|
Gaydukova I.Z., Mazurov V.I.
|
Vol 9, No 3 (2023) |
Intradialysis hypertension: Focus at high dialysis clearance of antihypertensive medicines |
|
Tokareva A.S., Borovkova N.Y., Lineva N.Y., Mazhukhina A.A., Mironov M.A.
|
Vol 10, No 3 (2024) |
Irritable bowel syndrome in new clinical practice |
|
Maev I.V., Osadchuk M.A., Osadchuk A.M.
|
Vol 10, No 5 (2024) |
Ischemic stroke in case of atrial fibrillation: influence of previous therapy at the early functional recovery of the patient |
|
Geraskina L.A., Maksimova M.Y., Fonyakin A.V., Garabova N.I., Burzhunova M.G.
|
Vol 9, No 1 (2023) |
Konstantin Aleksandrovich Shemerovsky is 75 |
|
Editorial B.
|
Vol 9, No 7 (2023) |
Laboratory markers for the risk of pulmonary embolism development in patients with malignant neoplasms |
|
Dimitrieva O.V., Tarasova L.V., Babokin V.E., Trofimov N.A.
|
Vol 9, No 4 (2023) |
Left-sided infectious endocarditis in a patient receiving program hemodialysis treatment |
|
Ponomareva E.Y., Sedov D.S.
|
Vol 9, No 9 (2023) |
Levels of interleukins 1β, 23, osteoprotegerin, receptor activator of nuclear factor-kappa B ligand in the dynamics of hypoxytherapy performing in female patients with autoimmune thyroiditis |
|
Ignatenko G.A., Maylyan E.A., Ignatenko T.S., Lesnichenko D.A., Valigun Y.S., Tumanova S.V.
|
Vol 10, No 9 (2024) |
Life, health, “life of disease” and the theory of general pathology |
|
Katz Y.A., Parkhonyuk E.V., Skriptsova S.A.
|
Vol 10, No 1 (2024) |
Life quality and prognosis of patients with adverse post-infarction left ventricle remodeling |
|
Salyamova L.I., Kvasova O.G., Babkina I.A., Rymar V.V.
|
Vol 10, No 2 (2024) |
Linear IgA-dependent bullous dermatosis as a rare type of vancomycin therapy complication: a clinical case |
|
Safronenko A.V., Gantsgorn E.V., Polyakova V.I., Gubin E.V., Rashkova E.V., Tuganov I.V.
|
Vol 9, No 4 (2023) |
Lipid-lowering therapy today and tomorrow |
|
Boeva O.I., Kokorin V.A., Latiy V.V.
|
Vol 10, No 4 (2024) |
Local therapy for osteoarthritis and periarticular soft tissue pathology: hyaluronic acid in focus |
|
Strebkova E.A., Alekseeva L.I.
|
Vol 9, No 6 (2023) |
Lung damage in rheumatoid arthritis: complex points of clinical practice |
|
Beketova M.F., Georginova O.A., Krasnova T.N.
|
Vol 10, No 3 (2024) |
Manifestation of extraintestinal ulcerative colitis symptomatic after colectomy |
|
Valitova A.D., Galieva A.M., Mukhametova D.D., Belousova E.N., Cheremina N.A., Odintsova A.K.
|
Vol 9, No 10 (2023) |
Meta-analysis of observational cohort studies on the relationships of asymptomatic hyperuricemia with chronic kidney disease |
|
Mazurov V.I., Drapkina O.M., Martynov A.I., Sayganov S.A., Bashkinov R.A., Gaydukova I.Z., Sapozhnikov K.V., Tolkacheva D.G., Sableva N.A., Tsinserling A.Y.
|
Vol 10, No 5 (2024) |
Metabolic comorbidity in case of cerebrovascular pathology |
|
Antonova K.V., Lagoda O.V., Shishkina T.S., Tanashyan M.M.
|
Vol 10, No 5 (2024) |
Metabolic markers of cerebrovascular pathology |
|
Tanashyan M.M., Antonova K.V., Spryshkov N.E., Panina A.A.
|
Vol 10, No 2 (2024) |
Metal nano- and microparticles-induced oral mucosa immunopathological inflammation |
|
Labis V.V., Bazikyan E.A., Sizova S.V., Khaidukov S.V., Zhigalina O.M., Khmelenin D.N., Dyachkova I.G., Zolotov D.A., Asadchikov V.E., Isakina M.O., Gildeeva G.N., Kozlov I.G.
|
Vol 11, No 1 (2025) |
Methodological recommendations (draft). Systemic lupus erythematosus: Diagnosis, treatment, monitoring (short version) |
|
Popkova Т.V., Panafidina T.A., Lila A.M.
|
Vol 9, No 2 (2023) |
MicroRNA-1 and microRNA-133: Small molecules of great importance in the aspect of cardiovascular diseases |
|
Aliyeva A.M., Teplova N.V., Butenko A.V., Averin E.E., Akhmedova M.F., Shikhova Y.A., Valiev R.K., Sariyev M.N., Kotikova I.A., Nikitin I.G.
|
Vol 9, No 10 (2023) |
Mineral density bone tissue disorder in case of inflammatory bowel diseases (literature review) |
|
Abdulganieva D.I., Kupkenova L.M., Yangurazova A.R., Myasoutova E.R.
|
Vol 9, No 2 (2023) |
Mixed infection with hepatitis A and E in combination with hemorrhagic fever with renal syndrome |
|
Shiryaeva M.A., Lebedeva N.N., Baranov A.E., Agarkova A.A., Malinnikova E.Y.
|
Vol 9, No 8 (2023) |
Modern approaches to colorectal cancer screening and prevention |
|
Bakulin I.G., Zharkov A.V., Serkova M.Y., Zhuravleva M.S.
|
Vol 11, No 2 (2025) |
Modern approaches to the diagnosis and treatment of sarcopenia in patients with chronic kidney disease |
|
Gasanov M.Z., Batyushin M.M., Veber V.R., Chulkov V.S., Azovtseva O.V.
|
Vol 9, No 8 (2023) |
Modern aspects of the use of acetylsalicylic acid in pregnant women |
|
Chulkov V.S., Nikolenko E.S., Chulkov V.S., Okonenko T.I., Zhmaylova S.V.
|
Vol 9, No 2 (2023) |
Modern aspects of the use of local hyaluronic acid in musculoskeletal diseases |
|
Strebkova E.A., Alekseeva L.I.
|
Vol 9, No 8 (2023) |
Modern aspects of use of tirzepatide – the first dual agonist of glucagon-like peptide-1 and glucosependent insulinotropic peptide receptors |
|
Usanova A.A., Lavrenova E.A., Kunyaeva T.A., Kuzma F., Novikova E.K., Sergutova N.P., Chatkina T.A.
|
Vol 9, No 4 (2023) |
Modern concepts concerning the mechanisms of iron absorption: activators, inhibitors, regulation, new possibilities of optimization |
|
Stuklov N.I., Gurkina A.A., Kovalchuk M.S., Kisly N.D.
|
Vol 10, No 1 (2024) |
Modern methods of surgical treatment of patients with rheumatic diseases |
|
Makarov M.A., Roskidailo A.A.
|
Vol 10, No 8 (2024) |
Modern opportunities for residual cardiovascular risk reducing |
|
Boeva O.I., Rzhevskaya E.V., Shkuta E.V., Baibuldin I.R., Drozdov V.V., Puchkova E.Y.
|
Vol 9, No 4 (2023) |
Modern opportunities for treatment of patient having chronic heart failure with low ejection fraction |
|
Roitberg G.E., Ardashev A.V., Zhelyakov E.G., Kondratova N.V., Merzyavko L.K., Ponkina N.K., Slastnikova I.D., Sokolov D.V.
|
Vol 11, No 1 (2025) |
Modern proton pump inhibitors: clinical advantages of esomeprazole |
|
Ketova G.G., Shamina O.M., Dolgushina A.I.
|
Vol 9, No 5 (2023) |
Modern strategies for safety of iron deficiency pharmacotherapy improving |
|
Shikh E.V., Makhova A.A., Krasnoperova E.V.
|
Vol 9, No 9 (2023) |
Modern viewpoint at prediabetes: Prevalence, diagnostic criteria, risk groups, screening |
|
Larina V.N., Lankin A.O., Larin V.G., Golovko M.G.
|
Vol 9, No 8 (2023) |
More on the neuroprotectory therapy evidential base: focus at ethylmethyl hydroxypyridine succinate |
|
Kochetkov A.I., Shatalova N.A., Klepikova M.V., Filippova T.V., Ostroumova O.D.
|
Vol 10, No 6 (2024) |
Mucoactive drugs in the treatment of patients with acute and chronic respiratory pathology |
|
Prozorova G.G., Budnevsky A.V., Chernik T.A.
|
Vol 9, No 4 (2023) |
Myocardial infarction in young men: androgen levels and predictors of post-hospital adverse cardiovascular events |
|
Tkachenko V.V., Tuev A.V., Karpunina N.S., Shishkina E.A.
|
Vol 9, No 4 (2023) |
Myocardial infarction type 1 at young age: contribution of proatherogenic factors and genetic thrombophilies |
|
Shushanova A.S., Gladkikh N.N., Yagoda A.V.
|
Vol 9, No 10 (2023) |
Neurorehabilitation after a stroke: what a therapist should know |
|
Shishkova V.N., Shishkov V.A.
|
Vol 10, No 9 (2024) |
New horizons in managing dyslipidemia – a risk factor for cardiovascular diseases |
|
Usanova A.A., Novikova E.K., Sergutova N.P., Kuzma F.M., Vasilkova A.S.
|
Vol 9, No 4 (2023) |
New opportunities for chronic heart failure patients’ treatment: focus at dapagliflosin |
|
Malimon V.V., Kokorin V.A.
|
Vol 10, No 8 (2024) |
New therapeutic opportunities of gastroprotection in cardiology |
|
Golendyaeva P.I., Livzan M.A., Korennova O.Y., Gaus O.V., Podolnaya S.P., Shkirinets A.V., Shukil L.V., Maltsev S.N.
|
Vol 9, No 5 (2023) |
Non-steroid anti-inflammatory drugs in musculoskeletal pain syndrome therapy: Aspects of their effective and safe use |
|
Dronova Y.M., Mubarakshina O.A., Chernov S.Y.
|
Vol 10, No 1 (2024) |
Nonsteroidal anti-inflammatory drugs in therapeutical practice |
|
Karateev A.E.
|
Vol 10, No 3 (2024) |
NSAIDs gastropathies in clinician’s practice |
|
Bakulin I.G., Avalueva E.B., Bakulina N.V., Serkova M.Y., Berest D.G., Pavlova E.Y.
|
Vol 10, No 3 (2024) |
Obesity in medical students: What has changed in 18 years |
|
Zhuchkova S.M., Busalaeva E.I., Markova T.N., Semenova V.A.
|
Vol 10, No 8 (2024) |
Obstructive sleep apnea syndrome, diabetes mellitus and cardiovascular complications |
|
Kazachenko A.A., Kulikov A.N., Tanich A.V.
|
Vol 9, No 5 (2023) |
Optimization of corticosteroid therapy for myastenia gravis |
|
Romanova T.V., Poverennova I.E., Persteneva N.P.
|
Vol 10, No 9 (2024) |
Origin and progression of creatininemia in working-age male patients, locomotive crew workers |
|
Lazutkina A.Y.
|
201 - 300 of 453 Items |
<< < 1 2 3 4 5 > >> |